We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Game Changing MRI-Compatible Robotics Platform to Improve Patient Outcomes in Neurosurgery

By HospiMedica International staff writers
Posted on 16 Mar 2022
Image: Portable MRI compatible surgical robot could be used in MRI Suite and OR (Photo courtesy of Unsplash)
Image: Portable MRI compatible surgical robot could be used in MRI Suite and OR (Photo courtesy of Unsplash)

Traditional approaches in robot-assisted surgery can be expensive, incompatible with existing surgical workflows, and incapable of meaningfully improving patient outcomes. An MRI-compatible robotics platform under development could prove cost-efficient, streamlined, and differentiated in its ability to help improve outcomes for patient undergoing neurosurgery for functional brain disorders (Parkinson's, Epilepsy, etc.) and cancer.

AiM Medical Robotics (Fort Lauderdale, FL, USA) is developing an industry-first MRI-compatible robotics platform, which is designed to improve outcomes for patients undergoing neurosurgery and provide cost savings to hospitals by eliminating errors and reducing procedure time by up to 50%. With a focus on bringing high levels of precision, automation, and efficiency to the complex environment of neurosurgery, the company is developing a portable MRI compatible surgical robot for use in the MRI suite and the operating room. AiM’s MRI-compatible robotics platform can be used with any diagnostic MRI scanner and will give surgeons the ability to utilize MRI guidance for complex neurosurgical procedures. By combining real time feedback of MRI and the precision and accuracy of the robot, surgeons can confidently reach targets deep in the brain the first time every time. AiM's MRI-compatible robotics platform opens the door to unprecedented levels of surgical precision and novel categories of surgical procedures.

"AiM is on an exciting journey to develop and commercialize an industry-first in robot-assisted surgery with our MRI-compatible robotics platform" said Bob Cathcart, CEO of AiM. "I am honored to have the support of our investors as we continue building our team of experts in robotics and medicine, and as we work towards our north star of improving patient outcomes in neurosurgery."

Related Links:
AiM Medical Robotics

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Multi-Chamber Washer-Disinfector
WD 390
Medical Examination & Procedure Light
Vega 80

Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more